UNSPSC 51141590: Donepezil hydrochloride

This classification denotes a cholinesterase inhibitor and nootropic agent with the molecular formula C24H29NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3O2T2PJ89D, chemically known as 1h-inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-((1-(phenylmethyl)-4-piperidinyl)methyl)-, hydrochloride but more generally known as donepezil hydrochloride, which bears US NIH Compound Identifier 5741.

UNSPSC 51141590 Donepezil hydrochloride is a Commodity code that nominally covers a specific pharmaceutical active ingredient used to treat Alzheimer's disease symptoms. However, the recent state and local solicitation activity tagged to this code shows a significant mismatch: Seminole County, Florida's IFB60459723LAS procurement, posted June 30, 2026 with a response deadline of July 26, 2023, solicits naloxone and drug deactivation systems for community health initiatives—products unrelated to donepezil hydrochloride. The code shows little relevant recent activity aligned with its stated pharmaceutical scope. State and local procurement offices appear to have applied this code to an opioid-reversal and drug-disposal procurement, suggesting either a data-entry error in the solicitation's UNSPSC assignment or a significant divergence between the code's intended use and how it is being applied in practice.

Seminole County's opportunity represents the only recent state and local solicitation visible under this code. The procurement seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit electronic bids including all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, comply with E-Verify requirements, and achieve drug-free workplace certification. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary period. Potential FEMA funding introduces additional federal compliance requirements. Businesses evaluating opportunities under this code should verify UNSPSC assignments with issuing bodies before pursuing, as the current tagging does not reflect the code's nominal pharmaceutical scope.